GURU.Markets stock price, segment price, and overall market index valuation
The company's share price NeuroPace Inc.
NeuroPace produces an implantable device for epilepsy treatment that monitors brain activity and prevents seizures. Its stock price is the story of the commercialization of this unique and valuable technology, which is changing the lives of patients.
Share prices of companies in the market segment - Therapeutic medical equipment
NeuroPace has developed the world's first and only neurostimulation system that monitors brain activity, detects abnormalities, and responds in real time to prevent epileptic seizures. We've classified it in the "Therapeutic Medical Equipment" segment. The chart below shows the dynamics of the breakthrough medical devices sector.
Broad Market Index - GURU.Markets
NeuroPace has developed the world's first implantable system that monitors brain activity and prevents epileptic seizures. As part of the GURU.Markets index, it is revolutionizing epilepsy treatment. The chart below represents the entire market. See how NeuroPace shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
NPCE - Daily change in the company's share price NeuroPace Inc.
The price fluctuations of NeuroPace, a manufacturer of medical devices for epilepsy treatment, reflect the dynamics of the medical technology market. Change_co demonstrates sensitivity to product news and its adoption. This indicator is an important component of formulas on System.GURU.Markets that assess volatility in the innovative medical equipment sector.
Daily change in the price of a set of shares in a market segment - Therapeutic medical equipment
NeuroPace, Inc. is a company in the medical device sector. This chart illustrates the high volatility of the MedTech industry. Comparing it to NPCE, which focuses on epilepsy treatment, helps assess whether its innovative products make it more or less volatile than the sector.
Daily change in the price of a broad market stock, index - GURU.Markets
NeuroPace is a manufacturer of an implantable device for preventing epileptic seizures. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how NeuroPace shares are responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization NeuroPace Inc.
NeuroPace, Inc.'s year-over-year performance is a story of commercializing its unique neurostimulation system for the treatment of epilepsy. Its market capitalization growth over the past 12 months reflects the growing number of patients receiving its RNS device, which not only prevents seizures but also collects data on brain activity, opening new horizons in treatment.
Annual dynamics of market capitalization of the market segment - Therapeutic medical equipment
NeuroPace, Inc. has developed the first and only neurostimulation system that responds to brain activity to prevent epileptic seizures. This chart shows how its breakthrough technology, growing adoption, and competition in the medical device sector are impacting its growth.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
NeuroPace, with its epilepsy implant, is a growth story in medicine. Its stock price is driven not by the economy, but by the speed of adoption by doctors and the insurance system. The chart reflects the potential of this breakthrough technology in the vast neurological market, regardless of the economic climate.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization NeuroPace Inc.
NeuroPace, a medical device manufacturer, is valued based on the adoption of its technology. The monthly fluctuations on the chart reflect the growth in implantations of its epilepsy treatment system, a key indicator of its operational growth and market penetration.
Monthly dynamics of market capitalization of the market segment - Therapeutic medical equipment
NeuroPace has developed the first and only neurostimulation system for epilepsy treatment that responds to abnormal brain activity in real time. The company's growth depends on the implementation of this cutting-edge technology. The medical device sector's chart reflects the overall interest in innovation, allowing us to assess the market potential of NeuroPace's unique product.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
NeuroPace develops implantable devices for epilepsy management. As a medical device manufacturer, the company depends on regulatory approval and the rapid adoption of its technology in clinics. Its shares are less sensitive to economic cycles than the overall market, and their performance reflects the success of its product commercialization.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization NeuroPace Inc.
NeuroPace has developed an implantable device to prevent epileptic seizures, placing it at the forefront of neurotechnology. The company's weekly stock price reflects the pace of adoption of its technology by surgeons, insurance company coverage decisions, and clinical data updates.
Weekly dynamics of market capitalization of the market segment - Therapeutic medical equipment
The neurotechnology sector, where NeuroPace operates, is driven by expectations of breakthrough treatments. The chart below reflects the general sentiment in this innovative niche. It allows one to assess how unique and in-demand the market perceives NeuroPace's technology compared to developments by other companies in this field.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
NeuroPace has developed an implantable system to prevent epileptic seizures. This is a breakthrough medical technology. The chart will show how much the company's stock price is driven by news of its implementation and commercial success, rather than by overall stock market sentiment.
Market capitalization of the company, segment and market as a whole
NPCE - Market capitalization of the company NeuroPace Inc.
NeuroPace's market capitalization is the investor valuation of its unique epilepsy treatment system. The chart shows how the market values its implantable device, which monitors brain activity and prevents seizures. The increase in this metric reflects the growing number of patients using this revolutionary technology.
NPCE - Share of the company's market capitalization NeuroPace Inc. within the market segment - Therapeutic medical equipment
NeuroPace developed and commercialized the world's first neurostimulation system for epilepsy treatment that responds to brain activity. In the therapeutic medical device segment, its market capitalization reflects the uniqueness and potential of this technology. The company's market share is an indicator of how widely its system is accepted by the medical community.
Market capitalization of the market segment - Therapeutic medical equipment
This chart shows the total value of the entire therapeutic medical device market. For NeuroPace, which developed a smart implant for epilepsy treatment, this line illustrates the scale of the neurological device market. The chart's growth reflects both overall medical progress and investor confidence that technology can offer solutions where drugs fail.
Market capitalization of all companies included in a broad market index - GURU.Markets
NeuroPace has developed an implantable system to prevent epileptic seizures. Its market capitalization is the valuation of a "smart" device that functions as a pacemaker for the brain. Overall, this represents the share of high technology in the treatment of neurological diseases.
Book value capitalization of the company, segment and market as a whole
NPCE - Book value capitalization of the company NeuroPace Inc.
NeuroPace developed the world's first neurostimulation system for the treatment of epilepsy. Its book value is derived from its technological and production assets: patents for its unique technology, R&D centers, and equipment for implant production. How did this neurotechnological capital grow? The chart below shows.
NPCE - Share of the company's book capitalization NeuroPace Inc. within the market segment - Therapeutic medical equipment
NeuroPace, Inc. has created a unique system for treating epilepsy, and it has a manufacturing base behind it. The company's balance sheet reflects the value of its manufacturing capacity for implantable neurostimulators and programming equipment. The chart shows its share of the physical infrastructure needed to create complex therapeutic devices.
Market segment balance sheet capitalization - Therapeutic medical equipment
NeuroPace, a manufacturer of medical devices for epilepsy treatment, is a capital-intensive business. It requires clean rooms and sophisticated equipment to create its neurostimulators. The BCap_Seg chart for the medical device sector shows that success requires a robust manufacturing base.
Book value of all companies included in the broad market index - GURU.Markets
NeuroPace's assets are not drugs, but rather a unique neurostimulation system, the RNS, which is implanted in the brain to prevent epileptic seizures. The balance sheet reflects the value of the technology, patents, and manufacturing equipment. The chart shows the material value of this pioneer in the field of neuromodulation.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - NeuroPace Inc.
NeuroPace's balance sheet is its factories and equipment. The market pays a high premium for its unique neurostimulation system, which doesn't just block but "listens" to the brain and prevents epileptic seizures. The chart is an assessment of its technological leadership and potential to save lives.
Market to book capitalization ratio in a market segment - Therapeutic medical equipment
NeuroPace has developed an implantable device for the treatment of epilepsy. It's a high-tech medical business. The chart shows how investors view its unique technology and its growth potential as it enters clinical practice, which requires time and investment.
Market to book capitalization ratio for the market as a whole
NeuroPace produces a neurostimulation system for the treatment of epilepsy. The company's value lies in its unique, FDA-approved technology and the data it collects. This creates a market valuation that is multiples of its book value, reflecting the demand for its innovative medical device.
Debts of the company, segment and market as a whole
NPCE - Company debts NeuroPace Inc.
NeuroPace, a company that developed a neurostimulation system for the treatment of epilepsy, is using debt to finance the commercialization of its product, R&D, and clinical trials. This chart shows how the MedTech company with a breakthrough technology is investing in expanding patient access to its device and proving its effectiveness.
Market segment debts - Therapeutic medical equipment
NeuroPace developed and commercialized a neurostimulation system for the treatment of epilepsy. As a medical device company, it incurs expenses for R&D, manufacturing, and, crucially, building a sales team to work with clinics. This chart shows how the company finances its commercial expansion and how much it relies on debt.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio NeuroPace Inc.
NeuroPace develops devices to treat neurological disorders such as epilepsy. It's a high-tech medical business that requires investment in R&D and clinical trials. This chart shows how the company finances its innovations. It reflects the balance between raising debt for development and the risks associated with bringing complex medical devices to market.
Market segment debt to market segment book capitalization - Therapeutic medical equipment
NeuroPace has developed the world's first neurostimulation system that responds to brain activity to prevent epileptic seizures. This is a breakthrough medical technology. The chart shows the debt burden in the medical device sector, which helps understand how NeuroPace is funding the commercialization of its unique product.
Debt to book value of all companies in the market
NeuroPace developed a system for treating epilepsy, which required significant investments in R&D and regulatory approvals. This chart shows the overall market debt burden. It helps understand how a medical device company manages its debt after commercialization and balances existing liabilities with new investments.
P/E of the company, segment and market as a whole
P/E - NeuroPace Inc.
NeuroPace has developed the world's first and only neurostimulation system that responds to brain activity to prevent epileptic seizures. This chart shows how the market is valuing its breakthrough technology. High values reflect confidence in the system's potential to transform the lives of epilepsy patients.
P/E of the market segment - Therapeutic medical equipment
NeuroPace is the manufacturer of a unique neurostimulation system for the treatment of epilepsy. This chart shows the average rating for the medical device sector. It shows the premium the market places on NeuroPace for its breakthrough, unparalleled technology compared to more traditional manufacturers.
P/E of the market as a whole
NeuroPace, Inc. has developed the world's first and only neurostimulation system that responds to brain activity in real time to prevent epileptic seizures. This chart reflects the overall sentiment in the medical technology sector. It helps us understand whether NPCE's high score reflects faith in its unique technology or is part of general optimism in the industry.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company NeuroPace Inc.
NeuroPace has developed an implantable system for epilepsy treatment that monitors brain activity and prevents seizures. Future revenue depends on the implementation of this cutting-edge technology. This chart reflects market expectations regarding growing demand for innovative medical devices and the commercial success of its product.
%20P%2FE%20NeuroPace%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-NeuroPace-Inc.&v=1772584459900 "Chart of the company's future (projected) P/E NeuroPace Inc.")
Future (projected) P/E of the market segment - Therapeutic medical equipment
NeuroPace has developed the world's first and only neurostimulation system that monitors brain activity, predicts, and prevents epileptic seizures. This chart reflects the company's future profitability expectations, demonstrating whether analysts believe this unique and expensive technology will be widely adopted into clinical practice.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Therapeutic-medical-equipment&v=1772584459919 "Future (projected) P/E graph of the market segment - Therapeutic medical equipment")
Future (projected) P/E of the market as a whole
NeuroPace has developed an implantable system to prevent epileptic seizures. This is a breakthrough medical technology. This chart of overall market expectations reflects investor appetite for companies that can dramatically improve patients' quality of life, even if the road to widespread adoption is long and expensive.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772584459951 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit NeuroPace Inc.
NeuroPace has developed the world's first and only neurostimulation system that responds to brain activity to prevent epileptic seizures. This graph shows the commercialization path for this unique medical device. Revenue growth depends on the adoption of this technology in clinical practice and the receipt of insurance coverage.
Profit of companies in the market segment - Therapeutic medical equipment
NeuroPace developed and commercialized the world's first neurostimulation system that responds to abnormal brain activity to prevent epileptic seizures. Its business operates at the intersection of medicine and high technology. The company's profitability depends on the implementation of this innovative technology in clinical practice and exemplifies advances in therapeutic devices.
Overall market profit
NeuroPace has developed and marketed the world's first neurostimulation system that responds to brain activity to prevent epileptic seizures. Demand for its technology is driven by medical indications. However, this demand, reflecting the state of the economy, affects the solvency of healthcare systems and patients, which may impact the speed of adoption of such an expensive technology.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company NeuroPace Inc.
NeuroPace has developed the first and only neurostimulation system that responds to abnormal brain activity to prevent epileptic seizures. This chart shows analysts' expectations for future revenue. The forecast depends on the speed of adoption of this innovative technology by neurosurgeons and the availability of insurance coverage for patients.
%20profit%20of%20the%20company%20NeuroPace%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-NeuroPace-Inc.&v=1772584460069 "Graph of future (projected) profit of the company NeuroPace Inc.")
Future (predicted) profit of companies in the market segment - Therapeutic medical equipment
NeuroPace has developed a unique neurostimulation system for epilepsy treatment that monitors brain activity and prevents seizures. Profitability forecasts for the medical device sector, shown on the graph, demonstrate the demand for innovation. This chart helps assess how NeuroPace's technology can transform patients' lives and carve out a niche in the market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Therapeutic-medical-equipment&v=1772584460079 "Graph of future (predicted) profits of companies in a market segment - Therapeutic medical equipment")
Future (predicted) profit of the market as a whole
NeuroPace develops and markets a neurostimulation system for the treatment of epilepsy. The implementation of such expensive medical equipment depends on insurance coverage and hospital budgets. In a strong economy, as indicated by the positive forecast in this graph, the healthcare system has more resources to invest in advanced technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772584460128 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - NeuroPace Inc.
NeuroPace has developed the world's first and only neurostimulation system that responds to brain activity to prevent epileptic seizures. This chart shows the premium investors are paying for revenue from this breakthrough technology. This high valuation reflects its uniqueness and potential to change patients' lives.
P/S market segment - Therapeutic medical equipment
NeuroPace developed the world's first and only neurostimulation system that monitors and responds to brain activity to prevent epileptic seizures. This chart shows the average revenue estimate in the medical device sector. It helps understand the market premium for the company's unique and breakthrough technology.
P/S of the market as a whole
NeuroPace has developed the world's first and only neurostimulation system that monitors brain activity, detects abnormalities, and responds to them to prevent epileptic seizures. This chart provides context for understanding how the market values the revenue of a company with a unique and breakthrough medical device relative to the overall market.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company NeuroPace Inc.
NeuroPace has developed the first and only neurostimulation system that responds to abnormal brain activity to prevent epileptic seizures. This chart shows how investors estimate its future earnings. This valuation is a bet on the wider adoption of this innovative technology in epilepsy treatment.
%20P%2FS%20NeuroPace%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-NeuroPace-Inc.&v=1772584460450 "The graph of the company's future (projected) P/S NeuroPace Inc.")
Future (projected) P/S of the market segment - Therapeutic medical equipment
NeuroPace has developed the world's first and only neurostimulation system that responds to brain activity to prevent epileptic seizures. This chart compares the company's estimated future sales with other medical device manufacturers. It reflects investor expectations for the implementation of this breakthrough technology and the expansion of its applications.
%20P%2FS%20market%20segment%20graph%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Therapeutic-medical-equipment&v=1772584460470 "Future (projected) P/S market segment graph - Therapeutic medical equipment")
Future (projected) P/S of the market as a whole
NeuroPace develops and markets a neurostimulation system for the treatment of epilepsy. It is a high-tech medical product. Demand for it is determined not by the economy, but by medical needs and the healthcare system's ability to pay for expensive treatment. This chart shows the general background, but NeuroPace's growth drivers lie in the medical field.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772584460566 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales NeuroPace Inc.
This graph shows the revenue of NeuroPace, a manufacturer of an implantable neurostimulation system for the treatment of epilepsy. Revenue is generated from sales of this high-tech device and is linked to the number of implantations performed. Revenue growth reflects the market penetration of this innovative technology and its acceptance by the medical community.
Sales of companies in the market segment - Therapeutic medical equipment
NeuroPace developed and commercialized the world's first neurostimulation system that monitors and responds to brain activity to prevent epileptic seizures. This chart shows revenue in the therapeutic medical device sector. It reflects the demand for innovative solutions for the treatment of chronic neurological diseases, where NeuroPace technology offers a unique approach.
Overall market sales
NeuroPace has developed and commercialized an implantable system for epilepsy treatment that responds to abnormal brain activity. Demand for this high-tech medical device is driven by medical needs. Economic cycles, as reflected in this graph, have little impact on decisions about performing such life-saving surgeries, but they do impact hospital budgets.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company NeuroPace Inc.
NeuroPace has developed a unique neurostimulation system that monitors brain activity and prevents epileptic seizures before they begin. This projected revenue chart reflects the pace of adoption of this cutting-edge technology. This growth is driven by expectations of an increasing number of patients and clinics using this innovative therapy.
%20sales%20of%20the%20company%20NeuroPace%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-NeuroPace-Inc.&v=1772584460868 "Schedule of future (projected) sales of the company NeuroPace Inc.")
Future (projected) sales of companies in the market segment - Therapeutic medical equipment
NeuroPace developed and commercialized the world's first neurostimulation system that responds to brain activity in real time to prevent epileptic seizures. This chart shows projected revenue for the therapeutic medical device sector, reflecting the demand for innovative devices to treat chronic neurological conditions.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Therapeutic-medical-equipment&v=1772584460885 "Schedule of future (projected) sales of companies in the market segment - Therapeutic medical equipment")
Future (projected) sales of the market as a whole
NeuroPace has developed an implantable system for epilepsy treatment. Demand for its technology is driven by medical needs. However, the economic situation impacts hospital budgets and insurance coverage. Stable economic growth, predicted by the market, ensures the sustainability of the healthcare system, making advanced technologies more accessible.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772584460917 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality NeuroPace Inc.
NeuroPace has developed a unique system for epilepsy treatment that monitors brain activity and prevents seizures. The profitability of this medical technology depends on production costs and insurance coverage. The chart shows the company's path to profitability through increased sales of implantable devices and consumables.
Market segment marginality - Therapeutic medical equipment
NeuroPace developed and commercialized the world's first neurostimulation system that responds to abnormal brain activity to prevent epileptic seizures. This chart compares the profitability of its innovative medical device. Technological leadership and product uniqueness allow the company to maintain high margins compared to other manufacturers.
Market marginality as a whole
NeuroPace has developed a unique neurostimulation system for the treatment of epilepsy that responds to brain activity in real time. Demand for their product is driven by medical needs, not the economic situation, as reflected in this graph. The company prioritizes clinical data, medical approval, and insurance coverage for their expensive technology.
Employees in the company, segment and market as a whole
Number of employees in the company NeuroPace Inc.
NeuroPace has developed the world's first and only neurostimulation system that responds to brain activity to prevent epileptic seizures. This chart shows the company's growing commercial and technical team. This increase is directly related to efforts to implement this sophisticated technology in epilepsy centers.
Share of the company's employees NeuroPace Inc. within the market segment - Therapeutic medical equipment
NeuroPace has developed a unique system for epilepsy treatment that monitors and responds to brain activity. Its business requires a team of engineers for development and a team of clinical specialists to support doctors and patients. This graph demonstrates its scale in the complex neurotechnology niche, reflecting its investment in human capital.
Number of employees in the market segment - Therapeutic medical equipment
NeuroPace has developed a unique neurostimulation system for epilepsy treatment that monitors brain activity in real time and prevents seizures. This graph illustrates the growth in the advanced medical device sector. The increase in engineers and clinical specialists reflects the adoption of this sophisticated technology and the training of physicians in its use.
Number of employees in the market as a whole
NeuroPace develops and markets implantable medical devices for the treatment of epilepsy. Its growing staff of engineers, physicians, and sales specialists reflects the adoption of high technology in medicine. This employment chart shows how the MedTech sector is creating high-paying jobs, changing treatment standards, and outpacing overall economic trends.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company NeuroPace Inc. (NPCE)
NeuroPace has developed the world's first and only neurostimulation system that monitors and responds to brain activity to prevent epileptic seizures. This is a breakthrough in medicine. This graph demonstrates the extremely high cost per employee, reflecting the value of the unique technology, patents, and intellectual capital created by the team of engineers and scientists.
%20of%20the%20company%20NeuroPace%20Inc.%20(NPCE)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-NeuroPace-Inc.-NPCE&v=1772584461102 "Chart of market capitalization per employee (in thousands of dollars) of the company NeuroPace Inc. (NPCE)")
Market capitalization per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
NeuroPace develops and markets implantable neurostimulators for the treatment of epilepsy. In the high-tech medical equipment industry, this metric reflects the value of innovation. It demonstrates the premium the market is willing to pay for the company's unique technology and the expertise of its team of engineers and doctors, compared to other medical equipment manufacturers.
%20by%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Therapeutic-medical-equipment&v=1772584461120 "Market capitalization per employee (in thousands of dollars) by market segment - Therapeutic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
NeuroPace has developed an implantable system for preventing epileptic seizures. This metric reflects the company's high-tech medical technology business. The company's value lies in its unique, FDA-approved device. Its team of engineers and clinicians has created a life-saving product, which accounts for its high market valuation.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772584461144 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company NeuroPace Inc. (NPCE)
NeuroPace produces an implantable medical device for epilepsy treatment that monitors brain activity and prevents seizures. This is high-tech medicine. This chart shows how profitable their business model (selling expensive devices and, potentially, data) is. Their high profit per employee is a result of the high margins of their unique technology.
%20Chart%20NeuroPace%20Inc.%20(NPCE)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-NeuroPace-Inc.-NPCE&v=1772584461163 "Company Profit Per Employee (in thousands of dollars) Chart NeuroPace Inc. (NPCE)")
Profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment
NeuroPace produces an innovative neurostimulation system that responds to brain activity to prevent epileptic seizures. It's a complex medical device. This performance indicator combines R&D expenditures (system improvements) with the productivity of a sales team serving a highly specialized medical market.
%20in%20the%20market%20segment%20-%20Therapeutic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Therapeutic-medical-equipment&v=1772584461191 "Chart of profit per employee (in thousands of dollars) in the market segment - Therapeutic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
NeuroPace has developed an implantable system for monitoring and treating epilepsy. It's a complex medical device (MedTech). This graph reflects the balance between the enormous costs of R&D and clinical trials, on the one hand, and revenue from sales of expensive devices and surgeon training, on the other. This is an indicator of efficiency in high-tech medicine.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772584461251 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee NeuroPace Inc. (NPCE)
NeuroPace develops and markets a neurostimulation system for the treatment of epilepsy. This chart shows the progress of this medical technology commercialization. Revenue per employee reflects the number of devices sold and implanted, a key indicator of the adoption of their technology by the medical community.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-NeuroPace-Inc.-NPCE&v=1772584461266 "Sales chart per company employee NeuroPace Inc. (NPCE)")
Sales per employee in the market segment - Therapeutic medical equipment
NeuroPace (NPCE) is a medical technology company that developed the world's first neurostimulation system that responds to brain activity to prevent epileptic seizures. This graph shows how much revenue each employee generates from sales of their implants. It's an indicator of the value of their unique technology and the effectiveness of their commercialization.
Sales per employee for the market as a whole
NeuroPace, Inc. produces the RNS system, an implantable device for epilepsy treatment that monitors brain activity and prevents seizures. This is a high-tech MedTech. This metric reflects how effectively the company sells its expensive device and its consumables. Growth here signifies the successful implementation of their technology in clinics.
Short shares by company, segment and market as a whole
Shares shorted by company NeuroPace Inc. (NPCE)
NeuroPace produces an implantable neurostimulation system for epilepsy management. This chart shows bearish bets. Bearish bets may be unsure about the speed of commercial adoption (convincing surgeons and patients is difficult) or whether the reimbursement system (insurance) will be sufficiently profitable for the company.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-NeuroPace-Inc.-NPCE&v=1772584461421 "Short Shares Chart for the Company NeuroPace Inc. (NPCE)")
Shares shorted by market segment - Therapeutic medical equipment
NeuroPace produces a "brain pacemaker"—an implantable device for epilepsy that responds to seizures. This chart shows bearish bets. "Short" bets here are that their technology is too niche, too expensive, or that doctors and patients will prefer competing treatments.
Shares shorted by the overall market
NeuroPace has developed a neurostimulation system for epilepsy treatment that responds to brain activity. It's high-tech medical equipment. This chart reflects the overall market anxiety. While medical equipment is a protective sector, expensive innovative systems could face reduced demand if hospitals begin cutting costs.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator NeuroPace Inc. (NPCE)
NeuroPace produces an implantable system for epilepsy treatment. Business depends on technology adoption and reimbursement. A chart above 70 may reflect strong growth in implantations. A range below 30 is often associated with slow adoption, reimbursement issues, or competition.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-NeuroPace-Inc.-NPCE&v=1772584461712 "RSI 14 indicator chart for the company's stock NeuroPace Inc. (NPCE)")
RSI 14 Market Segment - Therapeutic medical equipment
NeuroPace (NPCE) is a "pacemaker" for the *brain*. They produce an *implantable* system (RNS System) that *predicts* and *stops* epileptic seizures. The RSI_14_Seg for their segment (medtech) shows whether the sector is "overbought." This helps us differentiate: is NPCE's growth an "RNS niche" or a general "overheating"?
RSI 14 for the overall market
NeuroPace (NPCE), a manufacturer of epilepsy implants. This chart is an indicator of elective surgeries. During periods of euphoria and stability, patients confidently undergo expensive elective surgeries. During periods of market panic and rising unemployment, people, fearing loss of insurance, postpone "non-urgent" surgeries.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NPCE (NeuroPace Inc.)
NeuroPace (NPCE) has developed the RNS system, an implantable device ("brain pacemaker") that monitors and prevents epileptic seizures. This graph shows the average 12-month forecast, reflecting analysts' expectations for the pace of clinical adoption of this innovative technology.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NPCE-NeuroPace-Inc.&v=1772584461830 "A chart showing analyst consensus forecasts for the expected stock price. NPCE (NeuroPace Inc.)")
The difference between the consensus estimate and the actual stock price NPCE (NeuroPace Inc.)
NeuroPace is a medical device company that has developed a pacemaker for the brain. Their RNS system is an implant that monitors brain activity, predicts, and stops epileptic seizures that are not treatable with medication. This chart shows how confident analysts are in the commercialization of this breakthrough, but expensive, technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NPCE-NeuroPace-Inc.&v=1772584461833 "A chart showing the difference between the consensus forecast and the actual stock price. NPCE (NeuroPace Inc.)")
Analyst consensus forecast for stock prices by market segment - Therapeutic medical equipment
NeuroPace is a medical company that created the RNS System, a "pacemaker for the brain." It's an implant that monitors brain activity and prevents epileptic seizures before they begin. This chart shows general expectations for the therapeutic medical device sector, reflecting experts' confidence in this closed-loop technology.
Analysts' consensus forecast for the overall market share price
NeuroPace (NPCE) is the company that created the "brain pacemaker." Their implantable RNS system monitors brain activity in real time and prevents epileptic seizures. This is a breakthrough in neuroscience. This chart shows the overall risk appetite. It reflects the market's willingness to fund companies whose breakthrough medical technologies are changing the standard of care.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index NeuroPace Inc.
NeuroPace is a pacemaker for the brain. Their RNS System is an implantable device that listens to the brain, predicts epileptic seizures, and prevents them by sending a pulse. It's a closed-loop process. This graph is a barometer of their adoption. It likely reflects the rate of installation of their devices (razors) and their ability to generate revenue from consumables (blades).
AKIMA Market Segment Index - Therapeutic medical equipment
NeuroPace (NPCE) is a medtech innovator in neuroscience; the company produces the RNS System, the first (and only) implant (brain pacemaker) that monitors brain activity and prevents epileptic seizures. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this breakthrough technology (NPCE) differentiate it from the average medtech competitor?
The AKIM Index for the overall market
NeuroPace is a manufacturer of implantable RNS devices for epilepsy treatment that respond to brain activity. It's a "smart" pacemaker for the brain. This chart, reflecting the market average, is just the background. It helps assess how this high-tech MedTech story stacks up against overall macroeconomic trends and physician adoption.
